What they were paid
Monopar Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $31,000 | $0 | $46,457 | $0 | $77,457 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Monopar Therapeutics DEF 14A filed April 30, 2026, accession 0001437749-26-014183, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Monopar Therapeutics pays directors a $40,000 cash retainer.
The rest of the Monopar Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Arthur J. Klausner | Independent Director | $401,224 |
| Chandler D. Robinson, MD | Director | $0 |
| Christopher M. Starr, Ph.D | Chair of the Board | $536,724 |
| Kim R. Tsuchimoto | Independent Director | $389,937 |
| Lavina Talukdar | Independent Director | $225,331 |
| Nicole Sweeny | Independent Director | — |
| Raymond W. Anderson | Independent Director | $409,224 |
The full Monopar Therapeutics compensation record
free company briefThis page is one director within Monopar Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat